Wesana Health Holdings (XCNQ:WESA.X) Debt-to-Equity : -0.92 (As of Dec. 2023)

View and export this data going back to 2021. Start your Free Trial

What is Wesana Health Holdings Debt-to-Equity?

Wesana Health Holdings's Short-Term Debt & Capital Lease Obligation for the quarter that ended in Dec. 2023 was C$0.34 Mil. Wesana Health Holdings's Long-Term Debt & Capital Lease Obligation for the quarter that ended in Dec. 2023 was C$0.00 Mil. Wesana Health Holdings's Total Stockholders Equity for the quarter that ended in Dec. 2023 was C$-0.37 Mil. Wesana Health Holdings's debt to equity for the quarter that ended in Dec. 2023 was -0.92.

A high debt to equity ratio generally means that a company has been aggressive in financing its growth with debt. This can result in volatile earnings as a result of the additional interest expense.

The historical rank and industry rank for Wesana Health Holdings's Debt-to-Equity or its related term are showing as below:

XCNQ:WESA.X' s Debt-to-Equity Range Over the Past 10 Years
Min: -0.92 Med: -0.3 Max: 0.31
Current: -0.92

During the past 4 years, the highest Debt-to-Equity Ratio of Wesana Health Holdings was 0.31. The lowest was -0.92. And the median was -0.30.

XCNQ:WESA.X's Debt-to-Equity is not ranked
in the Biotechnology industry.
Industry Median: 0.14 vs XCNQ:WESA.X: -0.92

Wesana Health Holdings Debt-to-Equity Historical Data

The historical data trend for Wesana Health Holdings's Debt-to-Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Wesana Health Holdings Debt-to-Equity Chart

Wesana Health Holdings Annual Data

Trend

Apr20

Apr21

Dec22

Dec23

Debt-to-Equity

0.31

-0.92

Wesana Health Holdings Quarterly Data
	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Sep23	Dec23
Debt-to-Equity	Get a 7-Day Free Trial									-	0.09	0.31	0.64	-0.92

Competitive Comparison of Wesana Health Holdings's Debt-to-Equity

For the Biotechnology subindustry, Wesana Health Holdings's Debt-to-Equity, along with its competitors' market caps and Debt-to-Equity data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Wesana Health Holdings's Debt-to-Equity Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Wesana Health Holdings's Debt-to-Equity distribution charts can be found below:

* The bar in red indicates where Wesana Health Holdings's Debt-to-Equity falls into.

Wesana Health Holdings Debt-to-Equity Calculation

Debt to Equity measures the financial leverage a company has.

Wesana Health Holdings's Debt to Equity Ratio for the fiscal year that ended in Dec. 2023 is calculated as

Debt to Equity	=	Total Debt			/	Total Stockholders Equity
	=	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)	/	Total Stockholders Equity
	=	(0.335	+	0)	/	-0.366
	=	-0.92

Wesana Health Holdings's Debt to Equity Ratio for the quarter that ended in Dec. 2023 is calculated as

Debt to Equity	=	Total Debt			/	Total Stockholders Equity
	=	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)	/	Total Stockholders Equity
	=	(0.335	+	0)	/	-0.366
	=	-0.92

Wesana Health Holdings (XCNQ:WESA.X) Debt-to-Equity Explanation

In the calculation of Debt to Equity, we use the total of Short-Term Debt & Capital Lease Obligation and Long-Term Debt & Capital Lease Obligation divided by Total Stockholders Equity. In some calculations, Total Liabilities is used to for calculation.

Be Aware

Because a company can increase its ROE % by having more financial leverage, it is important to watch the leverage ratio when investing in high ROE % companies.

Wesana Health Holdings Debt-to-Equity Related Terms

Thank you for viewing the detailed overview of Wesana Health Holdings's Debt-to-Equity provided by GuruFocus.com. Please click on the following links to see related term pages.

Wesana Health Holdings (XCNQ:WESA.X) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Wesana Health Holdings Inc (XCNQ:WESA.X) » Definitions » Debt-to-Equity

Comparable Companies

Traded in Other Exchanges

WSNAF:USA

Address

745 Thurlow Street, Suite 2400, Vancouver, BC, CAN, V6E 0C5

Website

https://www.wesanahealth.com

Wesana Health Holdings Inc is an emerging life sciences company championing the development and delivery of psychedelic and naturally-sourced therapies to treat traumatic brain injury. The Company is developing evidence-based formulations and protocols that empower patients to overcome neurological, psychological, and mental health ailments caused by trauma with the help of extensive clinical research and academic partnerships.

Wesana Health Holdings (XCNQ:WESA.X) Headlines

No Headlines